First Trust Advisors LP Nevro Corp Transaction History

First Trust Advisors LP

$127 Billion
Q3 2025

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$36.43 - $49.4 $209,363 - $283,901	5,747 New	5,747 $227,000
Q4 2021 Feb 08, 2022	SELL	$81.07 - $121.29 $392,946 - $587,892	-4,847 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$101.99 - $166.36 $494,345 - $806,346	4,847 New	4,847 $564,000
Q2 2021 Aug 16, 2021	SELL	$141.6 - $179.06 $1.72 Million - $2.17 Million	-12,124 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$132.81 - $182.18 $62,155 - $85,260	-468 Reduced 3.72%	12,124 $1.69 Million

Q4 2020 Feb 02, 2021	SELL	$138.17 - $184.34 $529,467 - $706,390	-3,832 Reduced 23.33%	12,592 $2.18 Million
Q3 2020 Nov 05, 2020	SELL	$114.09 - $145.51 $1.1 Million - $1.41 Million	-9,683 Reduced 37.09%	16,424 $2.29 Million
Q2 2020 Jul 22, 2020	BUY	$89.45 - $129.85 $375,690 - $545,370	4,200 Added 19.17%	26,107 $3.12 Million
Q1 2020 May 06, 2020	SELL	$70.23 - $144.31 $905,615 - $1.86 Million	-12,895 Reduced 37.05%	21,907 $2.19 Million
Q4 2019 Feb 03, 2020	BUY	$76.41 - $117.54 $470,379 - $723,576	6,156 Added 21.49%	34,802 $4.09 Million
Q3 2019 Nov 04, 2019	SELL	$61.52 - $91.1 $561,493 - $831,469	-9,127 Reduced 24.16%	28,646 $2.46 Million
Q2 2019 Jul 30, 2019	BUY	$58.04 - $66.99 $2.19 Million - $2.53 Million	37,773 New	37,773 $2.45 Million
Q4 2018 Feb 07, 2019	SELL	$35.43 - $56.29 $760,469 - $1.21 Million	-21,464 Closed	0 $0
Q3 2018 Oct 25, 2018	SELL	$44.22 - $75.47 $33,032 - $56,376	-747 Reduced 3.36%	21,464 $1.22 Million
Q2 2018 Aug 02, 2018	BUY	$72.38 - $92.5 $1.37 Million - $1.75 Million	18,908 Added 572.45%	22,211 $1.77 Million
Q1 2018 Apr 23, 2018	SELL	$69.46 - $88.57 $381,752 - $486,780	-5,496 Reduced 62.46%	3,303 $286,000
Q4 2017 Feb 08, 2018	BUY	$65.94 - $93.31 $580,206 - $821,034	8,799	8,799 $607,000

Others Institutions Holding NVRO

# of Institutions

Shares Held

5.26M

Call Options Held

Put Options Held

150K

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $207M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account